Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Holding DE:137?
Track your performance easily

Aldeyra Therapeutics (137) Cash flow

0 Followers

Aldeyra Therapeutics Cash Flow

DE:137's free cash flow for Q was $-7.97M. For the fiscal year, DE:137's free cash flow was decreased by $26.33M and operating cash flow was $-7.97M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -30.67M$ -30.33M$ -56.64M$ -42.56M$ -37.49M$ -44.98M
Investing Cash Flow
$ -43.35M$ 30.00M$ -29.95M$ -7.81K$ 29.02M$ 18.48M
Financing Cash Flow
$ -1.19M$ -1.27M$ 1.22M$ 194.50M$ 41.90M$ 23.58M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 384.46M$ 142.82M$ 144.42M$ 229.79M$ 77.86M$ 43.82M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 1.77M$ 1.70M$ 1.34M$ 1.34M$ 1.39M$ 238.49K
Issuance Of Capital Stock
$ -217.26K--$ 189.81M$ 40.72M$ 7.89M
Issuance Of Debt
$ -1.04M$ -1.04M---$ 14.45M
Repayment Of Debt
$ -1.04M$ -1.04M----
Free Cash Flow
$ -30.67M$ -30.33M$ -56.65M$ -42.56M$ -37.49M$ -44.99M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Aldeyra Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis